Abbott's segment revenues 2017-2023

Abbot Laboratories is an international medtech and pharmaceutical company headquartered in Chicago, Illinois. In 2013, Abbott Laboratories was split into two companies: Abbot (medical products) and AbbVie (research-based pharmaceuticals). As of 2023, the medical devices segment was the largest segment within the company and generated 16.9 billion U.S. dollars in revenues. Abbot’s diagnostics segment was, prior to 2023, the largest generator of revenue but dropped to around ten billion U.S. dollars in 2023.

Abbott’s company profile

Abbott Laboratories was founded in 1888 in Chicago, where the company has remained since. The company operates in around 160 countries globally, covering therapeutic areas such as diabetes, diagnostics, nutrition and cardiovascular disease. The number of employees at Abbot Laboratories (Abbot and AbbVie) has increased over the last several years. The revenues of Abbott declined around the time the company was split in 2013 but has increased significantly recently. 

Abbott’s global positioning

Abbot Laboratories is among the top global health companies based on revenue. Furthermore, AbbVie, Abbott Laboratories’ spin-off company, was ranked second among the top global pharmaceutical companies based on prescription sales.